Veeva Sys Inc Stock Price, News & Analysis

Veeva Systems has launched Veeva Vault CRM for Medtech, a new unified CRM and content management application tailored for medtech sales teams and medical affairs professionals. This solution allows medtech companies to efficiently manage customer relationships and content without extensive customizations. Key features include inventory management, surgical case management, and stakeholder navigation. This application aims to enhance collaboration and streamline business processes across commercial and medical teams.

Veeva Systems (NYSE: VEEV) announced the launch of Veeva CDB, a new solution designed to streamline clinical data management by aggregating and transforming data from various sources. This platform aims to reduce complexity and costs in clinical trial data handling, allowing for centralized data query resolution and improved trial execution speed. Veeva CDB has supported over 100 trials, enhancing data visibility and enabling faster decision-making. It also introduces a Data Provider Program to standardize data delivery among sponsors, CROs, and providers.

Veeva Systems (NYSE: VEEV) unveiled Veeva ePRO on October 18, 2022, enhancing patient-centric digital trials. This application streamlines patient assessments via mobile devices and web browsers, enabling sponsors and research sites to access real-time data. Addressing challenges like lengthy trial participation and redundant data entry, Veeva ePRO improves patient experience. Integrated within the Veeva Vault Clinical Suite, it facilitates seamless communication and tracking, offering benefits for both patients and trial sponsors.

On October 17, 2022, Veeva Systems (NYSE: VEEV) announced that 40 contract research organizations (CROs), including four of the top six global CROs, have adopted the Veeva Vault CTMS to enhance clinical trial efficiency. This solution is now used by over 120 sponsors, including nine of the top 20 pharmaceutical companies, establishing it as the industry leader in clinical trial management. The Vault CTMS provides a comprehensive view of trial metrics, improving collaboration and study performance, which is essential for accelerating trial processes.

Veeva Systems (NYSE: VEEV) announced the launch of two new applications, Link SiteBase and Link TrialBase, aimed at enhancing clinical trial design and site selection. Set for release in April and October 2023, respectively, Link SiteBase helps identify and rank research sites, while Link TrialBase provides critical clinical trial intelligence. The innovations are designed to address challenges in trial execution, such as intense competition and protocol complexity, delivering comprehensive data to speed up trial outcomes.

Veeva Systems (NYSE: VEEV) announced that over 350 companies are leveraging its Veeva Vault RIM Suite applications to enhance regulatory processes. In the past year, more than 65 emerging biotechs adopted these solutions to improve submission planning and compliance with evolving regulations. Notable advancements include Active Dossier management, label change tracking, and non-eCTD electronic publishing. A top 20 pharma streamlined 19 million data points through the platform, reducing SOPs by 90%. The suite's new features aim to accelerate time to market for submissions.

Veeva Systems (NYSE: VEEV) will host a virtual financial analyst and investor day on November 3, 2022. The event starts at 9:00 a.m. PT and ends around 11:00 a.m. PT. Presentations will be broadcast live on the company's investor relations website, with an archived link available post-event. Interested participants can register online through the investor relations site. Veeva leads in cloud software for the life sciences sector, serving over 1,000 clients.

Veeva Systems (VEEV) announced two innovative Crossix solutions aimed at enhancing omnichannel marketing for life sciences companies. The HCP Trigger Data connects patient engagement data with healthcare professional visits, helping marketers prioritize outreach effectively. Meanwhile, Omnichannel Boost provides a unified view of HCP and patient engagement across various channels, optimizing marketing performance. These tools aim to deliver actionable insights that enhance patient outcomes and improve marketing strategies, leveraging data covering over 300 million lives in the U.S.

Veeva Systems (NYSE: VEEV) announced that Batavia Biosciences has selected its Veeva Vault Quality Suite to enhance global quality assurance (QA). The cloud-based platform will streamline QA processes, facilitating real-time insights for better compliance and inspection readiness. Batavia, a Dutch CDMO specializing in viral vaccines, aims to optimize QA management through centralized documentation and training. Veeva's solutions will improve collaboration, reactiveness to quality events, and scalability of QA oversight across operations.